Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$906K Buy
+18,816
New +$961K 0.19% 104
2026
Q1
$1.59M Sell
28,737
-3,829
-12% -$207K 0.12% 146
2025
Q4
$1.6M Buy
32,566
+3,527
+12% +$164K 0.12% 138
2025
Q3
$1.25M Buy
+29,039
New +$1.13M 0.16% 112
2024
Q3
– Sell
-8,413
Closed -$323K – 353
2024
Q2
$323K Sell
8,413
-15,729
-65% -$662K 0.03% 261
2024
Q1
$1.03M Buy
24,142
+1,127
+5% +$46.5K 0.11% 149
2023
Q4
$885K Buy
+23,015
New +$826K 0.09% 148

Other funds holding GSK

Leo Wealth's GSK Position: Q3 2026 in Review

Leo Wealth opened a new position in GSK (GSK) in Q3 2026: 18,816 shares worth $906K. The stake represents 0.19% of the portfolio and ranks #104 among its holdings. This is a return to the name: Leo Wealth previously reported a position in GSK as recently as Q1 2026.

Leo Wealth first reported a position in GSK in Q4 2023 and has held it in 7 quarters since. The position peaked at $1.6M in Q4 2025. 854 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Leo Wealth held 18,816 shares of GSK worth $906K as of Q3 2026.
  • GSK was a new Leo Wealth position in Q3 2026.
  • GSK made up 0.19% of Leo Wealth's portfolio in Q3 2026, its #104 holding.
  • Leo Wealth first reported a position in GSK in Q4 2023 and has held it in 7 quarters since.
  • Leo Wealth's GSK position peaked at $1.6M in Q4 2025.
  • 854 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Leo Wealth's 13F filing for Q3 2026, filed 26 Oct 2026.